Stratifying metabolic-related risk factors using latent class analysis to explore the risk of renal composite endpoints in patients with type 2 diabetes mellitus and associated chronic kidney disease

TL;DR

This study uses a statistical method to group patients with type 2 diabetes and kidney disease based on their metabolic profiles, revealing different risks for kidney outcomes.

Contribution

The study introduces a novel approach using latent class analysis to stratify patients with T2DM and CKD based on comprehensive metabolic profiles.

Findings

Class 2 patients showed significantly higher levels of multiple metabolic risk factors compared to Class 1.

Class 2 patients had increased hazard ratios for renal outcomes at 3, 5, and 10 years.

The method identifies distinct subgroups with different kidney disease prognoses.

Abstract

Metabolic syndrome is a key independent risk factor for the progression of chronic kidney disease (CKD) in patients with Type 2 diabetes (T2DM). Traditional studies often focus on isolated metabolic markers, but our research aims to comprehensively assess the metabolic landscape of these patients. Existing approaches have been limited in integrating multiple metabolic parameters and stratifying patients based on the severity of metabolic dysregulation, hindering the understanding of disease progression.

This single-center, retrospective cohort study was conducted at Guangdong Provincial People’s Hospital, enrolling 860 participants from January 2010 to December 2023. A total of 65.0% were male, and 35.0% were female. Using Latent Class Analysis (LCA), we stratified CKD patients with T2DM into two distinct classes based on a comprehensive set of baseline clinical metabolic indicators, including glycated hemoglobin (HbA1c), lipid profiles, serum uric acid, blood pressure and body mass index (BMI). Cox proportional hazards models were used to assess renal outcome risks across these identified metabolic phenotypes.

LCA revealed that Class 2 exhibited significantly higher values for clinical parameters including systolic and diastolic blood pressure, BMI, total cholesterol, triglycerides, LDL-C, HbA1c, and protein-to-creatinine ratio. Longitudinal analysis showed increased hazard ratios for renal outcomes at 3, 5, and 10 years for Class 2 (HR: 1.718, 1.662, and 1.826, respectively; all P < 0.05).

This study highlights the utility of comprehensive metabolic profiling through LCA for stratifying CKD patients with T2DM, identifying two distinct subgroups with differential renal prognoses, and offering insights for precision nephrology interventions and personalized risk management.

Figures